scispace - formally typeset
R

Reinhard Lorenz

Researcher at Ludwig Maximilian University of Munich

Publications -  82
Citations -  4199

Reinhard Lorenz is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Platelet & Platelet activation. The author has an hindex of 33, co-authored 82 publications receiving 3945 citations. Previous affiliations of Reinhard Lorenz include University of Düsseldorf.

Papers
More filters
Journal ArticleDOI

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups

TL;DR: Data do not confirm the supposed increased risk for IFN‐α–induced mental side effects and dropouts in psychiatric patients if interdisciplinary care and antidepressant treatment are available, and preexisting psychiatric disorders or present methadone substitution should no longer be regarded as contraindications to treatment of chronic hepatitis C with IFN-α and ribavirin in an interdisciplinary setting.
Journal ArticleDOI

IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY): Effects on Platelet Aggregation and Thromboxane Formation

TL;DR: The reduced toxicity with full efficacy favours a low and infrequent dosage of aspirin, which effectively blocked platelet throm boxane formation and thromboxane-supported aggregation on collagen and was safe in the postoperative phase.
Journal ArticleDOI

Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry.

TL;DR: The data indicate a high prevalence of comorbidities in patients with PA, defined by a higher morbidity than the normokalemic variant regarding some cardiovascular but not cerebrovascular events, and PA should be sought not only in hypokalemia but also in normokAlemic hypertensives because high-excess morbidity occurs in both subgroups.
Journal ArticleDOI

Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease—a randomized, placebo-controlled, double-blind cross-over trial

TL;DR: Despite a moderate reduction in inflammatory lipid mediators by dietary n‐3 fatty acids and limited morphological improvement in chronic inflammatory bowel disease, the clinical benefit seems to be confined to patients with ulcerative colitis.
Journal ArticleDOI

Adrenal Venous Sampling: Evaluation of the German Conn's Registry

TL;DR: Success rate in a retrospective analysis and comparison with procedures done prospectively after introduction of measures designed to improve rates of successful cannulation demonstrate the importance of throughput, expertise, and various potentially beneficial measures to improve adrenal vein sampling.